JAK inhibitors in autoinflammatory syndromes? The long road from drug development to daily clinical use

被引：5
|
作者：
Guilpain, Philippe [1 ,2 ,3 ]
机构：
[1] St Eloi Hosp, Dept Internal Med & Multiorgan Dis, Local Referral Ctr Syst & Autoimmune Dis, Montpellier, France
[2] Univ Montpellier, Fac Med, Montpellier, France
[3] St Eloi Hosp, Inst Regenerat Med & Biotherapy IRMB, Inserm U1183, Montpellier, France
来源：
RHEUMATOLOGY | 2023年 / 62卷 / 04期
关键词：
SAFETY;
D O I：
10.1093/rheumatology/keac592
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1368 / 1369
页数：2
相关论文
共 50 条
  • [1] The long and winding road in pharmaceutical development of canakinumab from rare genetic autoinflammatory syndromes to myocardial infarction and cancer
    Gram, Hermann
    PHARMACOLOGICAL RESEARCH, 2020, 154
  • [2] Autoinflammatory Syndromes - from Research to Clinical Applications
    Welsch, K.
    Yazdi, A. S.
    AKTUELLE DERMATOLOGIE, 2013, 39 (12) : 529 - 537
  • [3] Akt inhibitors in cancer treatment: The long journey from drug discovery to clinical use
    Nitulescu, George Mihai
    Margina, Denisa
    Juzenas, Petras
    Peng, Qian
    Olaru, Octavian Tudorel
    Saloustros, Emanouil
    Fenga, Concetina
    Spandidos, Demetrios A.
    Libra, Masimo
    Tsatsakis, Aristidis M.
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 48 (03) : 869 - 885
  • [4] The long road of biopharmaceutical drug development: from inception to marketing
    Mundae, M. K.
    Ostor, A. J. K.
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2010, 103 (01) : 3 - 7
  • [5] Clinical use of Jak 1 inhibitors for rheumatoid arthritis
    Nash, Peter
    RHEUMATOLOGY, 2021, 60 (SUPPL 2) : ii31 - ii38
  • [6] Clinical use of Jak 1 inhibitors for rheumatoid arthritis
    Nash, Peter
    RHEUMATOLOGY, 2021, 60 : II31 - II38
  • [7] Daily use of PDE5-inhibitors: The road to happiness?
    Gratzke, Christian
    EUROPEAN UROLOGY, 2008, 54 (01) : 28 - 30
  • [8] Myelofibrosis Drug Development through the Decade: Novel JAK Inhibitors
    Khan, Ali Younas
    Tariq, Muhammad Junaid
    Usman, Muhammad
    Ijaz, Awais
    Rafae, Abdul
    Malik, Mustafa Nadeem
    Fazeel, Hafiz Muhammad
    Parr, Nadia Carenina Nunes Cavalcante
    Fraz, Muhammad Asad
    Khalil, Muhammad Jahanzeb
    Jose, Jemin Aby
    Durer, Seren
    Durer, Ceren
    Anwer, Faiz
    BLOOD, 2018, 132
  • [9] SAFETY OF JAK INHIBITORS IN PATIENTS WITH RHEUMATOID ARTHRITIS IN CONDITIONS OF DAILY CLINICAL PRACTICE
    Cid Boza, Natalia
    Velloso Feijoo, M. L.
    Nahia, Plaza
    Luis Marenco, Jose
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1681 - 1682
  • [10] The clinical use of DNA methyltransferase inhibitors in myelodysplastic syndromes
    Abou Zahr, Abdallah
    Aldin, Ehab Saad
    Barbarotta, Lisa
    Podoltsev, Nikolai
    Zeidan, Amer M.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2015, 15 (09) : 1019 - 1036
12345